Historically drugs drug screening assays antitumor. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy19

Cell Line, Tumor Tumor Cells, Cultured T-Lymphocytes, Cytotoxic Dendritic Cells Killer Cells, Natural Lymphocytes, Tumor-Infiltrating T-Lymphocytes HT29 Cells CD4-Positive T-Lymphocytes T-Lymphocytes, Regulatory Spleen Cell Line Cells, Cultured Myeloid Cells K562 Cells HL-60 Cells KB Cells HCT116 Cells Macrophages

Organisms12

Mice, Nude Mice, Inbred BALB C Mice, Inbred C57BL Mice, SCID Oncolytic Viruses Adenoviridae Mice, Inbred DBA Streptomyces Mice, Inbred C3H Mice, Inbred Strains Mice, Transgenic Mice, Inbred ICR

Diseases45

Leukemia P388 Sarcoma 180 Neoplasms, Experimental Melanoma, Experimental Neoplasms Leukemia L1210 Carcinoma, Lewis Lung Sarcoma, Experimental Melanoma Fibrosarcoma Lung Neoplasms Colonic Neoplasms Ophthalmia Neonatorum Neovascularization, Pathologic Mammary Neoplasms, Experimental Carcinoma, Ehrlich Tumor Leukemia L5178 Leukemia, Experimental Breast Neoplasms Ovarian Neoplasms Adenocarcinoma Neoplasm Metastasis Disease Models, Animal Kidney Neoplasms Prostatic Neoplasms Liver Neoplasms Lymphoma Mast-Cell Sarcoma Brain Neoplasms Carcinoma, Renal Cell Liver Neoplasms, Experimental Pancreatic Neoplasms Glioma Carcinoma, Hepatocellular Neuroblastoma Glioblastoma Skin Neoplasms Gliosarcoma Thymoma Carcinoma, Squamous Cell Plasmacytoma Lymphoma, B-Cell Head and Neck Neoplasms Carcinoma, Non-Small-Cell Lung Carcinoma

Chemicals and Drugs106

Antineoplastic Agents Antibiotics, Antineoplastic Cancer Vaccines Enediynes Antineoplastic Agents, Phytogenic Antigens, Neoplasm Antibodies, Monoclonal Angiogenesis Inhibitors Doxorubicin Immunotoxins Ellipticines Interferon-gamma Cisplatin Interleukin-2 Interleukin-12 Camptothecin Prodrugs Naphthacenes Antineoplastic Agents, Alkylating Indoles Intercalating Agents Zinostatin Topoisomerase I Inhibitors Paclitaxel Plicamycin Antibodies, Neoplasm Quinazolines Adjuvants, Immunologic Protein Kinase Inhibitors Receptor, PAR-1 Drug Carriers Pyrroles Aminoglycosides Enzyme Inhibitors Aminoacridines Liposomes Recombinant Proteins Fluorouracil Cyclophosphamide Amsacrine gp100 Melanoma Antigen Anthraquinones Mitomycin Xanthones Topoisomerase II Inhibitors Maytansine Pyrazines Antibodies, Monoclonal, Humanized Deoxycytidine Mitomycins Acridines Benzoquinones Nitrogen Mustard Compounds Antimetabolites, Antineoplastic Cytokines Taxoids Antigens, CD80 Streptonigrin Plant Extracts DNA Naphthoquinones Neoplasm Proteins Membrane Glycoproteins MART-1 Antigen Boronic Acids Organoplatinum Compounds Pyrimidines Receptor, erbB-2 Dioxoles Recombinant Fusion Proteins Aziridines Receptor, Epidermal Growth Factor Depsipeptides Topotecan Phenylurea Compounds Thiazoles Tubulin Modulators Saralasin Lactones Pyridines Benzenesulfonates Antibodies, Bispecific Growth Inhibitors Immunoconjugates Antigens, CD Antigens, CD137 Histone Deacetylase Inhibitors Glycosides Pyrones Vaccines, DNA DNA, Neoplasm Picibanil Granulocyte-Macrophage Colony-Stimulating Factor Sulfonamides Pyrazoles Niacinamide Polyethylene Glycols Tumor Necrosis Factor-alpha Maleic Anhydrides Phospholipid Ethers Carbazoles Dacarbazine Nanocapsules Epothilones Pyrans Vascular Endothelial Growth Factor A

Analytical, Diagnostic and Therapeutic Techniques and Equipment46

Drug Screening Assays, Antitumor Xenograft Model Antitumor Assays Neoplasms, Experimental Neoplasm Transplantation Melanoma, Experimental Immunotherapy Immunotherapy, Adoptive Transplantation, Heterologous Injections, Intralesional Oncolytic Virotherapy Genetic Therapy Sarcoma, Experimental Tumor Burden Inhibitory Concentration 50 Antineoplastic Combined Chemotherapy Protocols Mammary Neoplasms, Experimental Flow Cytometry Drug Administration Schedule Combined Modality Therapy Drug Evaluation, Preclinical Lymphocyte Activation Leukemia, Experimental Drug Carriers Disease Models, Animal Injections, Intraperitoneal Blotting, Western Drug Delivery Systems Administration, Oral Transfection Treatment Outcome Lethal Dose 50 Gene Transfer Techniques Maximum Tolerated Dose Transduction, Genetic Liver Neoplasms, Experimental Magnetic Resonance Spectroscopy Tumor Stem Cell Assay Lymphocyte Depletion Injections, Subcutaneous Immunohistochemistry Adoptive Transfer Drug Design Nanocapsules Infusions, Intravenous Injections, Intravenous Cytotoxicity Tests, Immunologic

Phenomena and Processes34

Drug Synergism Apoptosis Cell Proliferation Dose-Response Relationship, Drug Cytotoxicity, Immunologic Cell Survival Inhibitory Concentration 50 Cell Division Genetic Vectors Molecular Structure Tumor Escape Structure-Activity Relationship Drug Resistance, Neoplasm Lymphocyte Activation Cell Growth Processes Cell Cycle Signal Transduction Time Factors Antibody-Dependent Cell Cytotoxicity Fermentation Gene Expression Regulation, Neoplastic Transfection Lethal Dose 50 Maximum Tolerated Dose Transduction, Genetic Immunity, Cellular Tissue Distribution Tumor Microenvironment Cell Death Immunity Chemical Phenomena Down-Regulation Transgenes Stereoisomerism

Disciplines and Occupations3

Immunohistochemistry Chemistry Drug Design

Technology, Industry, Agriculture4

Liposomes Polyethylene Glycols Nanocapsules Nanoparticles

Health Care1

Treatment Outcome

Anatomy Organisms Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Phenomena and Processes Disciplines and Occupations Technology, Industry, Agriculture Health Care

Drug Screening Assays, Antitumor Xenograft Model Antitumor Assays Antineoplastic Agents Cell Line, Tumor Leukemia P388 Antibiotics, Antineoplastic Mice, Nude Sarcoma 180 Neoplasms, Experimental Neoplasm Transplantation Melanoma, Experimental Cancer Vaccines Mice, Inbred BALB C Tumor Cells, Cultured Neoplasms Leukemia L1210 Immunotherapy Mice, Inbred C57BL Immunotherapy, Adoptive Drug Synergism Enediynes Apoptosis Mice, SCID Cell Proliferation Transplantation, Heterologous Carcinoma, Lewis Lung Antineoplastic Agents, Phytogenic Antigens, Neoplasm Dose-Response Relationship, Drug Injections, Intralesional Oncolytic Virotherapy Genetic Therapy Cytotoxicity, Immunologic Sarcoma, Experimental Melanoma Antibodies, Monoclonal T-Lymphocytes, Cytotoxic Cell Survival Fibrosarcoma Lung Neoplasms Oncolytic Viruses Colonic Neoplasms Ophthalmia Neonatorum Tumor Burden Angiogenesis Inhibitors Dendritic Cells Killer Cells, Natural Inhibitory Concentration 50 Adenoviridae Doxorubicin Cell Division Lymphocytes, Tumor-Infiltrating Immunotoxins Neovascularization, Pathologic Genetic Vectors Mice, Inbred DBA Antineoplastic Combined Chemotherapy Protocols Mammary Neoplasms, Experimental Ellipticines Flow Cytometry Streptomyces Molecular Structure Interferon-gamma Cisplatin Interleukin-2 Carcinoma, Ehrlich Tumor Interleukin-12 T-Lymphocytes Camptothecin Prodrugs Naphthacenes Antineoplastic Agents, Alkylating Drug Administration Schedule Indoles Combined Modality Therapy Tumor Escape Structure-Activity Relationship Intercalating Agents Zinostatin Drug Evaluation, Preclinical Drug Resistance, Neoplasm Topoisomerase I Inhibitors Mice, Inbred C3H Lymphocyte Activation Leukemia L5178 Paclitaxel Leukemia, Experimental Cell Growth Processes Plicamycin Antibodies, Neoplasm Cell Cycle Breast Neoplasms Quinazolines Adjuvants, Immunologic Signal Transduction Time Factors Protein Kinase Inhibitors Receptor, PAR-1 Antibody-Dependent Cell Cytotoxicity Ovarian Neoplasms

No FAQ available that match "historically drugs drug screening assays antitumor"